The FDA Isn’t Broken, It’s Bought

Of all the government agencies that need to be shut down or completely overhauled, the Food and Drug Administration tops the list.

If you’ve seen Dopesick or Painkiller, you already know why. It was eye-opening for me. Honestly, maybe I should be a little embarrassed it took me this long to see it. The people sounding the alarm years ago — the ones everyone brushed off as “crazy” — turned out to be dead right.

And now, a new study is making the rounds — at least in the corners of the internet that haven’t been sanitized by Big Pharma.

If you thought the FDA was looking out for you, think again.

One Pill, One Big Lie

The chemical abortion pill isn’t just ending babies’ lives — it’s harming the women who take it.

A new study, covered by the New York Post, found that nearly 11% of chemical abortions end in serious health complications — far higher than what the FDA has been claiming. We’re talking about infections, massive blood loss, emergency surgeries, sepsis — not the “safe and simple” procedure the marketing likes to promise. Researchers analyzed more than 865,000 cases over a six-year period, and the real-world data blows the FDA’s official narrative to pieces. Once again, the so-called “experts” sold a lie, and women are paying the price.

The Foundation for the Restoration of America identified at least 692,873 patients who obtained 865,727 chemical abortions from 2017 to 2023 for their review.

The FDA initially OK’d mifepristone for chemical abortions up to seven weeks into a pregnancy — a timeframe that was later extended to 10 weeks under former President Barack Obama.

Former President Joe Biden also opened the door to FDA approval of mifepristone prescriptions online or through the mail, which the Supreme Court upheld in a unanimous ruling last year. – The New York Post

Yet the FDA has spent years pushing this pill as “safe and effective.” Their official paperwork claims the serious risk rate is less than half a percent. Somebody’s lying.

Our team analyzed 865,727 mifepristone abortions (2017–2023), 28 times larger than all FDA clinical trials combined.

Here’s what we found:
· 10.93% of women experienced severe or life-threatening events within 45 days of taking Mifepristone, including sepsis, hemorrhage, blood… pic.twitter.com/3EAoGf0R75

— Ethics and Public Policy Center (@EPPCdc) April 28, 2025

Will that finally change now that Robert F. Kennedy Jr. is running HHS and Marty Makary is the new FDA Commissioner?

We’ll see. But don’t hold your breath.

Makary has been a prominent voice on U.S. health care practices, advocating for efforts to lower the cost of treatment and reduce unnecessary procedures and medical errors. During the COVID-19 pandemic, he questioned elements of the nation’s response—he was an early advocate for universal masking and vaccines, but later spoke out against vaccine mandates as well as prolonged school closures, masks for toddlers, and CDC guidelines for reopening schools. – Johns Hopkins

Since 2020 and the COVID “pandemic,” I’ll never fully trust anything that comes out of the government again — no matter who’s president or which party controls Congress.

COVID changed me. And it started under Donald J. Trump in 2020.
I don’t fully blame him — he was trusting the so-called “expert doctors,” just like the rest of us were expected to. But still, trust once broken doesn’t just snap back.
So yes, I support him now — but it’s a guarded support.

Question Everything

We move forward, but the blind trust is gone for good.

Meanwhile, the people running the FDA are busy polishing their résumés. Because once they rubber-stamp these drugs? They walk right out the door and into cushy, high-paying jobs at the very companies they were supposed to regulate.

This isn’t a conspiracy theory. It’s happening right out in the open.

The FDA’s leaders aren’t just bad at their jobs — they’re busy networking for their next one. They work side-by-side with Big Pharma to rush approvals, then cash out. Sound familiar? It’s the same playbook that helped fuel the opioid crisis. (Watch Dopesick if you need a refresher.)

Megyn Kelly pressed FDA Commissioner Marty Makary on how to stop government workers from cozying up to Big Pharma, fast-tracking approvals, and then cashing out. His big solution?

“I don’t know, we live in a free country.”

Translation: The grift goes on — and he’s not about to stop it.

They call it “public service.” I call it corruption with a desk badge.

And don’t think it’s just a few bad apples. The entire system is rigged to benefit industry first and patients dead last. Whether it’s pushing dangerous abortion pills, fast-tracking barely-tested drugs, or “streamlining approvals” to fatten corporate profits, the FDA has made one thing clear:

They are not to be trusted.

Shut the revolving door. Ban government-to-industry career moves cold. Tear it down and rebuild it from the ground up. Until then, if the FDA tells you something’s safe, you might want to read the fine print — and then read it again.

No Action Taken

As far as the safety of the Mifepristone (baby killer pill), Makary said he has no plan to take the drug off the market.

From EndPoint News –

‘I have no plans to take action on mifepristone’ 

So said Makary in the interview. When asked if his stance on the abortion pill could change given “the political forces at play on this,” Makary said more data were coming in on the safety of the drug and that would be considered in any potential policy change moving forward.

“We’re not going to act on that data that we have not yet seen,” he said. – EndPointNews

More safety data keeps coming in, and yet the drug is still on the market? How about pulling it until the research is actually finished?

Feature Image: Created in Canva Pro

---

Meet the voice here at An Americanist